Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

Name: Pivotal bioVenture Partners Investment Advisor LLC Q1 2021 13F Filing | 13F Explorer
Creator: Pivotal bioVenture Partners Investment Advisor LLC
Published: 2021-05-14

Location: San Francisco, CA

CIK: 0001844645 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value: $312M (100.0% shares, 0.0% debt)

Holdings (9)

— KARUNA THERAPEUTICS INC 35.1%

Value $109M Shares 908,708 Est. Cost $101.59 Unrealized —

— BOLT BIOTHERAPEUTICS INC 20.0%

Value $62.25M Shares 1,891,467 Est. Cost $32.91 Unrealized —

— INOZYME PHARMA INC 10.1%

Value $31.5M Shares 1,591,154 Est. Cost $20.64 Unrealized —

PCVX VAXCYTE INC 8.9%

Value $27.76M Shares 1,405,421 Est. Cost $37.18 Unrealized -32.3%

— AKOUOS INC 8.0%

Value $24.88M Shares 1,794,088 Est. Cost $19.83 Unrealized —

— ALIGOS THERAPEUTICS INC 6.4%

Value $19.93M Shares 876,548 Est. Cost $27.65 Unrealized —

— FUSION PHARMACEUTICALS INC 5.5%

Value $17.14M Shares 1,598,379 Est. Cost $11.75 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 5.3%

Value $16.46M Shares 569,041 Est. Cost $24.49 Unrealized +27.5%

— ENTASIS THERAPEUTICS HLDGS I 0.8%

Value $2.517M Shares 1,176,378 Est. Cost $2.47 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	908,708	$109M	35.1%	$101.59	—	COM	48576A100
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$62.25M	20.0%	$32.91	—	COM	097702104
—	INOZYME PHARMA INC	1,591,154	$31.5M	10.1%	$20.64	—	COM	45790W108
PCVX	VAXCYTE INC	1,405,421	$27.76M	8.9%	$37.18	-32.3%	COM	92243G108
—	AKOUOS INC	1,794,088	$24.88M	8.0%	$19.83	—	COM	00973J101
—	ALIGOS THERAPEUTICS INC	876,548	$19.93M	6.4%	$27.65	—	COM	01626L105
—	FUSION PHARMACEUTICALS INC	1,598,379	$17.14M	5.5%	$11.75	—	COM	36118A100
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$16.46M	5.3%	$24.49	+27.5%	COM	03969K108
—	ENTASIS THERAPEUTICS HLDGS I	1,176,378	$2.517M	0.8%	$2.47	—	COM	293614103